Thalitero capsule

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Thalitero capsule belongs to a group of medicines that have effects on the immune system, and contains thalidomide. Its labelling describes it for the treatment of multiple myeloma and lepra reaction. It is described as activating the body’s immune system to attack cancer cells and as stopping the growth of blood vessels in cancer. It is a prescription medicine; the doctor chooses the dose and duration according to the patient’s health condition.

Active ingredient
Thalidomide
Dosage form
Oral hard capsule
Therapeutic class
Immunomodulatory agent (IMiD)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of multiple myeloma
  • Described for the treatment of lepra reaction
  • Described as activating the immune system to attack cancer cells and stopping the growth of blood vessels in cancer
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Used only as per the advice of the doctor
  • The doctor chooses the dose and duration according to the patient’s health conditions

Described Side Effects

Described side effects include:

  • Anxiety, confusion, and sleepiness
  • Constipation
  • Tremors and sensory neuropathy
  • Change in body weight
  • Thromboembolism
  • Muscle pain and muscle weakness
  • Anaphylactic reaction
  • Decreased potassium level in the blood
  • Headache
  • Nausea
  • Rash
  • Breathlessness and dizziness
  • Edema (swelling)
  • Fatigue

Most of these are described as not lasting long; a doctor should be consulted if symptoms last a long time.

Precautions

  • Described as unsafe for pregnant mothers
  • Breastfeeding mothers should consult a doctor before use
  • Described as safe for kidney patients if prescribed by a doctor
  • Described as safe for patients with liver issues if advised by the doctor

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains thalidomide and is used for the treatment of multiple myeloma and lepra reaction. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as activating the body’s immune system to attack cancer cells and stopping the growth of blood vessels in cancer.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services